Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network (2021) Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, et al. Journal article, Review article Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage (2021) Fernandez De Larrea C, Kyle R, Rosinol L, Paiva B, Engelhardt M, Usmani S, Caers J, et al. Journal article Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients (2021) Xydia M, Rahbari R, Ruggiero E, Macaulay I, Tarabichi M, Lohmayer R, Wilkening S, et al. Journal article Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastases (2021) Offermann A, Kang D, Watermann C, Weingart A, Hupe MC, Saraji A, Stegmann-Frehse J, et al. Journal article Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative (2021) Kayser S, Schlenk RF, Lebon D, Carre M, Goetze KS, Stoelzel F, Berceanu A, et al. Journal article An in vitro evaluation of the biological and osteogenic properties of magnesium-doped bioactive glasses for application in bone tissue engineering (2021) Hohenbild F, Arango Ospina M, Schmitz SI, Moghaddam A, Boccaccini AR, Westhauser F Journal article Correction to: Innovative radiation oncology Together—Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany (Strahlentherapie und Onkologie, (2021), 197, 12, (1043-1048), 10.1007/s00066-021-01843-9) (2021) Krug D, Hecht M, Ebert N, Maurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article, Erratum Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021) Jaramillo S, Krisam J, Le Cornet L, Kratzmann M, Baumann L, Sauer T, Crysandt M, et al. Journal article DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status (2021) Jurmeister P, Weber K, Villegas S, Karn T, Untch M, Thieme A, Mueller V, et al. Journal article SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report (2021) Gerber TS, Agaimy A, Hartmann A, Habekost M, Roth W, Stenzinger A, Schirmacher P, Straub BK Journal article